共 168 条
[1]
Gamble P(2021)Determining breast cancer biomarker status and associated morphological features using deep learning Commun Med 1 14-34
[2]
Jaroensri R(2010)Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance Clin Med Insights Oncol 4 15-3277
[3]
Wang H(2019)Prognostic models for breast cancer: a systematic review BMC Cancer 19 230-95
[4]
Tan F(2017)Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility Int J Mol Sci 18 363-1177
[5]
Moran M(2010)Metastatic behavior of breast cancer subtypes J Clin Oncol 28 3271-43
[6]
Brown T(2018)Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort BMC Cancer 18 171-52
[7]
Taneja P(2011)Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancer Cancer Res Treat 43 89-5280
[8]
Maglic D(2013)Prognostic factors for patients with bone-only metastasis in breast cancer Yonsei Med J 54 1168-539
[9]
Kai F(2020)The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients EBioMedicine 51 863-1568
[10]
Zhu S(2022)hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors Cancers (Basel) 14 35-4477